Published • loading... • Updated
PET Scan Data Joins Clinical Factors to Predict Relapse in MALT Lymphoma
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PET Scan Data Joins Clinical Factors to Predict Relapse in MALT Lymphoma
Researchers in Wuhan have built a prognostic nomogram that combines FDG PET/CT metabolic imaging with clinical and pathological variables to predict progression-free survival in MALT lymphoma, achieving moderate validated accuracy and refining risk within the intermediate-risk group.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
